In conclusion, our study indicates that the clinical phenotypic presentation associated to TARDBP mutations, and in particular to the p.N267S variant, may expand beyond the classical ALS and FTD spectrum to include also PD and atypical parkinsonisms. This evidence concerns the gene TARDBP and Parkinson disease.